Next Article in Journal
Role of Clay Minerals in Natural Media Self-Regeneration from Organic Pollution-Prospects for Nature-Inspired Water Treatments
Next Article in Special Issue
Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells
Previous Article in Journal
Co-Mn Complex Oxide Nanoparticles as Potential Reactive Oxygen Species Scavenging Agents for Pulmonary Fibrosis Treatment
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cordyceps Polysaccharides: A Review of Their Immunomodulatory Effects

1
School of Comprehensive Health Management, Xihua University, Chengdu 610097, China
2
School of Food and Bioengineering, Xihua University, Chengdu 610097, China
3
Sichuan Chinese Herb Preparation, Chengdu 611732, China
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(21), 5107; https://doi.org/10.3390/molecules29215107
Submission received: 25 August 2024 / Revised: 27 October 2024 / Accepted: 28 October 2024 / Published: 29 October 2024

Abstract

:
Cordyceps primarily consists of ascomycetes, a parasitic fungus that infects insects and arthropods. Recently, Cordyceps has been shown to manifest a diverse range of pharmacological activities, rendering it applicable for the treatment and mitigation of various diseases, such as diabetes, acute liver injury, and colitis. Many active constituents have been identified from Cordyceps sinensis, including cordycepin, adenosine, sterols, and polysaccharides. Polysaccharides constitute a primary active component of Cordyceps, exhibiting immunomodulatory effects. We searched the Web of Science database with the keywords of cordyceps, polysaccharide, and immune modulation; collected related studies from 2004 to 2024; and eliminated articles with low influence and workload. A review of the research advancements regarding the immunomodulatory effects of Cordyceps polysaccharides was conducted with the aim of furnishing valuable reference information. Research indicates that polysaccharides exhibiting immunomodulatory activity are predominantly sourced from Cordyceps sinensis and Cordyceps militaris. Immunological experimental results demonstrate that Cordyceps polysaccharides can augment the activities of macrophages, lymphocytes, and dendritic cells while fostering the expression of immune-active substances such as cytokines and chemokines. Furthermore, animal experiments have substantiated the immunomodulatory effects of Cordyceps polysaccharides. These effects encompass ameliorating immune suppression induced by drugs or radiation, enhancing immune organ indices, elevating the expression of immunoreactive substances, and mitigating immune evasion prompted by tumors. In conclusion, Cordyceps polysaccharides exhibit significant immunomodulatory activity and merit further investigation.

1. Introduction

Cordyceps predominantly comprises ascomycetes parasitic fungi, which flourish through parasitism in insects and arthropods, encompassing orders such as Coleoptera, Hemiptera, Hymenoptera, Lepidoptera, and Diptera. Furthermore, a minor fraction of Cordyceps exhibits parasitic behavior toward other fungi [1]. The diversity in parasitic fungi and their corresponding hosts contributes to the varied forms observed within the genus Cordyceps. Consequently, the Cordyceps genus presently comprises over 750 identified species [2]. In the genus Cordyceps, Cordyceps sinensis (the new species name is Ophiocordyceps sinensis) and Cordyceps militaris emerge prominently as the two most renowned and widely utilized species [3]. Empirical evidence indicates that these species have demonstrated utility in the treatment and amelioration of a spectrum of diseases, encompassing, but not limited to, cancer, diabetes, cardiovascular disease, liver damage, and kidney damage [4,5]. This has garnered global interest in utilizing Cordyceps and their derivatives for medicinal, dietary, or tonic purposes.
With the increasing attention directed toward Cordyceps, extensive research has been undertaken to investigate its bioactive components. Polysaccharides are acknowledged as principal bioactive constituents in Cordyceps [6]. Mounting evidence from pharmacological studies indicates that Cordyceps polysaccharides exhibit a diverse array of biological activities [7]. Among these, the immunomodulatory activity of Cordyceps polysaccharides stands out prominently [8]. Hence, with the aim of furnishing scholars with comprehensive and valuable insights, this article reviews the immunomodulatory effects of Cordyceps polysaccharides, encompassing both the polysaccharide fraction and purified polysaccharides characterized by a singular structure. These polysaccharides comprise intracellular polysaccharides extracted from fruiting bodies or mycelium, as well as extracellular polysaccharides extracted from the fermentation broth of artificially cultivated Cordyceps. Cordyceps sinensis and Cordyceps militaris stand out as the two most extensively studied types of Cordyceps [9]. Moreover, several studies have indicated that polysaccharides extracted from Cordyceps cicadae, Cordyceps kyushuensis, Cordyceps gunnii, Cordyceps taii, and Cordyceps sobolifera also exhibit immunomodulatory activity [10]. Experimental findings reveal that both the polysaccharide fraction and purified polysaccharides exert immunomodulatory effects on various pivotal immune cells, such as macrophages, lymphocytes, and dendritic cells [11]. These effects encompass the augmentation of cellular activity, stimulation of cell proliferation, and enhancement of the expression of immune substances [12,13]. Furthermore, animal experiments demonstrate a significant enhancement in immune organ indices upon the administration of these polysaccharides [14,15]. Cordyceps polysaccharides exhibit efficacy in ameliorating immune suppression induced by drugs, radiation, and other factors, as well as in stimulating the immune system to combat tumors [16,17]. Presently, there is a lack of comprehensive discussion regarding the immunomodulatory effects of Cordyceps polysaccharides. In this study, we conducted a comprehensive analysis of the immunomodulatory effects of Cordyceps polysaccharides, providing a significant reference for elucidating their immunomodulatory mechanism, which deserves further exploration.

2. Immunomodulatory Activity of Polysaccharides from Cordyceps sinensis

Owing to its extensive utilization and elevated market value, Cordyceps sinensis is the most extensively investigated species within the Cordyceps genus. In China, Cordyceps sinensis is even recognized as the sole species within the genus officially listed as a medicinal substance in the Chinese Pharmacopoeia [18]. As key bioactive constituents of Cordyceps sinensis, polysaccharides have garnered growing interest due to their immunomodulatory properties [9]. Presently, the predominant technique for extracting polysaccharides from Cordyceps sinensis involves the hot water extraction method. Methods such as ultrasonic-assisted and microwave-assisted extraction are also employed to improve extraction efficiency [19]. The principal purification techniques for Cordyceps sinensis polysaccharides encompass ion exchange chromatography and gel chromatography [20]. Chemical structure characterization involves techniques such as gas chromatography–mass spectrometry, high-performance liquid chromatography, infrared spectroscopy, and nuclear magnetic resonance, which are employed for analyzing structural features of polysaccharides, including molecular weight, configuration of glycosidic bonds, and monosaccharide composition [21]. To date, besides the polysaccharide fraction, 17 purified polysaccharides characterized by a singular structure have been confirmed to exhibit immunomodulatory activity. Their chemical structures are summarized in Table 1.

2.1. Immunomodulatory Effects of Intracellular Polysaccharides on Immune Cells

Macrophages play a pivotal role in the immune process, possessing the capability to phagocytose and digest diverse pathogens. Furthermore, macrophages exhibit the capacity to activate other immune cells, particularly T lymphocytes, through processes such as antigen presentation and the release of cytokines, thereby instigating specific immune responses. In essence, the multifaceted functions of macrophages render them an indispensable and integral component of the immune system [57]. Evidence suggested that the Cordyceps sinensis polysaccharide fraction (25–100 μg/mL) induced a shift in the M2 phenotype of Ana-1 macrophages to the M1 phenotype. This shift activated macrophage immune activity, upregulating tumor necrosis factor-α (TNF-α), interleukin-12 (IL-12), and inducible nitric oxide synthase (iNOS) expression, while downregulating IL-10. Further research revealed that these effects were attributed to nuclear factor-κB (NF-κB) pathway activation and reduced expression of the mannose receptor and scavenger receptor [58]. Chen et al. and Meng et al. reported that the Cordyceps sinensis polysaccharide fraction (30–300 μg/mL) enhanced the phagocytic activity of RAW264.7 macrophages. Additionally, it stimulated the release of NO and cytokines IL-1α, IL-1β, IL-10, and TNF-α through the activation of the IκB/NF-κB pathway [59,60]. The Cordyceps sinensis polysaccharide fraction (0.1–15 μg/mL) not only enhanced macrophage activity but also induced RAW 264.7 macrophage differentiation into dendritic cells. Moreover, it promoted the maturation of mouse JAWS II dendritic cells by increasing the surface levels of cluster of differentiation 80 (CD80), CD86, and major histocompatibility complex class II (MHC II) antigen presentation molecules [61]. These studies demonstrate that the polysaccharide fraction of Cordyceps sinensis activates macrophage immune activity, promotes the expression of immune substances, and induces differentiation, with the NF-κB pathway activation playing a key role in this process.
In addition to the polysaccharide fraction, some purified polysaccharides characterized by a singular structure have been discovered to exert activation effects on macrophages. Furthermore, characterization of the chain conformation of pure polysaccharides indicates that they are predominantly composed of glucans. The polysaccharide NCSP-50 is a glucan with a molecular weight of 976 kDa. It comprises a main chain of (1→4)-linked α-D-Glcp with a single α-D-Glcp branch substituted at C-6. The immunomodulatory experiments unveiled that NCSP-50 (25–200 μg/mL) induced the proliferation of RAW 264.7 cells and augmented the production of NO, along with the cytokines IL-1β and TNF-α [34]. The polysaccharide CCP is a glucan with a molecular weight of 433.788 kDa, composed of non-reducing terminal D-Glcp, (1→4)-linked D-Glcp, and (1→4,6)-linked D-Glcp residues. Both Li et al. and Tan et al. have documented that CCP (1–400 μg/mL) induced the production of NO, IL-6, and TNF-α in RAW 264.7 cells through the activation of the toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88)/p38 mitogen-activated protein kinase (p38) signaling pathway [22,62]. The polysaccharide HSWP-2a is a glucan with a molecular weight of 870.70 kDa. Further characterization of the chain conformation of HSWP-2 revealed that it is an α-(1→4)-D-glucan that branches at O-6, O-3, or O-2 with a terminal 1-linked α-D-Glcp as a side chain. HSWP-2a (25–200 μg/mL) augmented the phagocytic activity of RAW264.7 cells and elevated the production of NO, IL-1β, IL-6, and TNF-α through the activation of the p38, c-Jun N-terminal kinase (JNK), and NF-κB signaling pathways. Furthermore, HSWP-2a enhanced the proliferation of mouse splenic lymphocytes [32]. The polysaccharide UM01-S4 is a heteropolysaccharide with a molecular weight of 22.569 kDa. The monosaccharide composition includes mannose, glucose, galactose, and galacturonic acid with a molar ratio of 9.6:4.0:4.4:1.0. Characterization of the chain conformation of UM01-S4 indicated that it features a backbone of α-(1→2)-Manp with side chains consisting of β-(1→4)-Glcp, β-(1→2)-Galf, terminal α-GalpA, and α-Manp. Immunological findings suggested that UM01-S4 (0.1–3 μg/mL) boosted the proliferation and phagocytic activity of RAW 264.7 cells. Additionally, it stimulated the release of NO and cytokines IL-1β, IL-6, IL-12, and TNF-α through the activation of the mitogen-activated protein kinase (MAPK) and NF-κB signaling pathways [27]. The polysaccharide cordysinan is a hyperbranched heteropolysaccharide with a molecular weight of 22.37 kDa. Its monosaccharide composition comprises mannose, galactose, and glucose with a molar ratio of 4.4:3.8:1.0, with the primary backbone composed of 1,2-Manp residues. Cordysinan (10–100 μg/mL) induced the release of various cytokines, including IL-1β, IL-6, IL-10, and TNF-α, as well as chemokines such as monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α), interferon-inducible protein-10 (IP-10), and keratinocyte-derived chemokine (KC) from RAW 264.7 cells [26]. In summary, these studies collectively suggest that Cordyceps sinensis polysaccharides have the potential to enhance macrophage phagocytosis and stimulate cytokine and chemokine production by activating the MAPK and NF-κB signaling pathways.
Hao et al. identified that in addition to exerting immunomodulatory effects on macrophages, the Cordyceps sinensis polysaccharide fraction counteracted immunosuppression in mouse spleen lymphocytes induced by simulated microgravity, promoted lymphocyte proliferation, and enhanced CD4 and CD8 expression. However, it was noteworthy that the promoting effect was observed at concentrations of 25 and 50 μg/mL, while above a concentration of 50 μg/mL, it transitioned to an inhibitory effect [63].

2.2. Immunomodulatory Effects of Intracellular Polysaccharides in Animal Models

Cyclophosphamide is a frequently employed chemotherapy drug known for its immunosuppressive effects. Its actions encompass inhibiting the activity of lymphocytes, attenuating the immune system’s memory response to immune stimuli, and diminishing cytokine production. Furthermore, cyclophosphamide can induce apoptosis in immune cells, leading to a reduction in their numbers [64]. Numerous scholars have explored the immunomodulatory effects of Cordyceps sinensis polysaccharides on cyclophosphamide-induced intestinal immune dysfunction. Fan et al. found that the Cordyceps sinensis polysaccharide fraction (200 mg/kg) increased histone H3 acetylation, which in turn mediated the specific expression of forkhead box protein P3 (Foxp3) in regulatory T cells, as well as decreased IL-17 and IL-21 expression in the colons of mice induced with cyclophosphamide [65]. Chen et al. discovered that the Cordyceps sinensis polysaccharide fraction (25–100 mg/kg) could enhance intestinal mucosal immunity and regulate the polarization of T helper type 1 (Th1)/Th2 cells in immunosuppressed cyclophosphamide-induced mice. The expression of Th1-style cytokines IL-2, IL-12 p40, interferon-γ (IFN-γ), and TNF-α, as well as Th2 cytokines IL-4, IL-10, and transcription factor GATA binding protein 3 (GATA-3) increased. Moreover, there was a rise in the formation of immunoglobulin A (IgA)-secreting cells and the content of secretory IgA [66]. Ying et al. also discovered that the Cordyceps sinensis polysaccharide fraction (25–100 mg/kg) could ameliorate cyclophosphamide-induced intestinal mucosal immunosuppression in mice. It stimulated the secretion of cytokines IL-12, IFN-γ, IL-4, IL-13, IL-6, IL-17, IL-10, transforming growth factor-β3 (TGF-β3), TNF-α, IL-2, and IL-21, as well as the production of transcription factors T-box expressed in T cells (T-bet), GATA-3, retinoic acid receptor-related orphan receptor γT (RORγt), and Foxp3 through the activation of the TLR/NF-κB signaling pathway [67]. In addition to the polysaccharide fraction, glucan NCSP-50 (25–100 mg/kg) could ameliorate cyclophosphamide-induced intestinal damage in mice by elevating the number of CD4+ T cells, modulating the expression of TLRs, and increasing the levels of cytokines associated with Th17 cells (IL-17 and IL-21) and Treg cells (TGF-β3) in the small intestine [68]. Taken together, these studies indicate that Cordyceps sinensis polysaccharides improve cyclophosphamide-induced intestinal immunosuppression by activating T-cell immune activity and inducing the expression of multiple cytokines and chemokines.
In addition to ameliorating cyclophosphamide-induced immunosuppression, Cordyceps sinensis polysaccharides have demonstrated the ability to inhibit radiation-induced immunosuppression. The Cordyceps sinensis polysaccharide fraction (50–200 mg/kg) enhanced the immune function of mice exposed to 60Co by improving lymphocyte proliferation and macrophage phagocytic activity. Additionally, it reduced the expression of IL-4 and IL-17 while increasing the expression of IL-5 [28]. Yang et al. also discovered that the Cordyceps sinensis polysaccharide fraction (100–400 mg/kg) could enhance survival rates and times in X-ray-irradiation-injured mice. It accelerated the recovery of white blood cells, increased the organ indices of the thymus and spleen, and elevated the DNA content in bone marrow cells by activating the MAPK signaling pathway [69]. In essence, Cordyceps sinensis polysaccharides ameliorate immune damage induced by radiation by reinstating both the quantity and functionality of immune cells.
Current research also indicates that Cordyceps sinensis polysaccharides can exert anti-cancer effects by enhancing immune function. Tan et al. discovered that the Cordyceps sinensis polysaccharide fraction (100–400 mg/kg) could elevate the thymus index, spleen index, and the numbers of CD4+, CD8+ T lymphocytes, and macrophages in the spleen. This inhibited the proliferation of cancer cells in H22 tumor-bearing mice [22].
Additionally, research indicates that Cordyceps sinensis polysaccharides have potential as a vaccine adjuvant. The polysaccharide PS is a heteropolysaccharide with a molecular weight of 83 kDa. The monosaccharide composition includes glucose, mannose, arabinose and galactose in a molar ratio of 8:90:1:1. Immunological experimental results demonstrated that PS (100–400 μ/mouse) could enhance the serum levels of IgG, IgG1, and IgG2b in ovalbumin (OVA)-immunized mice [35].

2.3. Immunomodulatory Effects of Extracellular Polysaccharides on Immune Cells

Due to the exorbitant cost of natural Cordyceps sinensis, scholars have endeavored to artificially cultivate Cordyceps sinensis to extract relevant biologically active substances. Strains isolated from natural Cordyceps sinensis are cultivated on a culture medium to obtain mycelium. The culture medium becomes enriched with extracellular polysaccharides produced by these Cordyceps sinensis fungi [70]. Current research indicates that, unlike intracellular polysaccharides primarily regulating macrophage activity, exopolysaccharides exhibit immunomodulatory effects on a diverse range of immune cells. These include macrophages, dendritic cells, and lymphocytes.
Through isolation and purification, scholars have obtained three pure polysaccharides, AEPS-1, OSP, and HS002-II, all demonstrating immunomodulatory effects on macrophages. Immunological experimental results demonstrated that AEPS-1 (25–250 μg/mL), OSP (6.25–50 μg/mL), and HS002-II (0.2785–4.4 μM) enhanced the phagocytic activity of RAW264.7 cells and induced the production of NO and cytokines TNF-α, IL-6, and IL-1β. This was achieved by activating the MAPK, NF-κB, and phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathways [44,45,46]. Chemical structure characterization revealed that AEPS-1 is an acidic glucan with a molecular weight of 36 kDa. It possesses a linear backbone of (1→3)-linked α-D-Glcp residues with two branches, α-D-Glcp and α-D-Glcp, attached to the main chain by (1→6) glycosidic bonds at every seventh α-D-Glcp unit [29]. The polysaccharide OSP is a heteropolysaccharide with a molecular weight of 27.972 kDa. Its monosaccharide composition includes xylose, mannose, glucose, and galactose in a ratio of 2.9:6.6:166:2.6 [25]. The molecular weight of the polysaccharide HS002-II is 44 kDa, and its monosaccharide composition is highly complex. It includes mannose, ribose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, xylose, and arabinose in a molar ratio of 6.47:2.27:1.25:0.69:0.42:65.89:16.17:2.13:4.26. Characterization of the chain conformation of HS002-II revealed that it mainly comprises a long backbone of (1→3)-linked α-d-Ribf units, (1→4)-linked α-d-Xylp units, and (1→4)-linked β-d-Glcp units, which was substituted at C-6 [33].
Dendritic cells are a crucial subset of immune cells with the primary function of presenting antigens and activating T lymphocytes [71]. Current research shows immune-activating effects on dendritic cells of two pure exopolysaccharides, namely, EPS and UST 2000. Chemical structure characterization revealed that the molecular weight of EPS is 104 kDa, and its monosaccharide composition comprises glucose and galactose in a ratio of 23:1:2.6. Immunological experimental results demonstrated that EPS (25–100 μg/mL) promoted the maturation and activation of mouse dendritic cells and increased the expression of IL-12, TNF-α, and iNOS and upregulated their capacity for antigen uptake and activation of CTLL-2 T lymphocyte proliferation. Subsequent investigations revealed that this was attributed to inhibition of signal transducer and activator of transcription 3 (STAT3) phosphorylation, leading to an increase in the expression of surface molecules such as MHC-II, CD40, CD80, and CD86 [72,73]. Sheng et al.’s study also verified that the activation of dendritic cells by EPS (25–100 μg/mL) heightened the proliferation of lymphocytes in the mouse spleen and thymus and elevated the expression of TNF-α, IFN-γ, and IL-2 [30]. In addition to EPS, the polysaccharide UST 2000 (6.25–100 μg/mL) promoted the proliferation of human T lymphocytes and the secretion of IL-2, IL-6, and IL-8 by activating the extracellular signal-regulated kinase (ERK) signaling pathway. Chemical structure characterization revealed that the molecular weight of UST 2000 is 82 kDa, and its monosaccharide composition comprises glucose, mannose, and galactose in a ratio of 2.4:2:1 [36]. In summary, these studies indicate that Cordyceps sinensis exopolysaccharides stimulate dendritic cell immune activity and induce T lymphocyte immune activation.

2.4. Immunomodulatory Effects of Extracellular Polysaccharides in Animal Models

The results of mouse immunosuppression experiments show that two pure extracellular polysaccharides, PHP and EPS, improve immune suppression by stimulating T lymphocyte immune activity and cytokine expression. The polysaccharide PHP is a water-soluble polysaccharide with a molecular weight of 58.14 kDa, and its monosaccharide composition includes mannose (2.49%), glucose (57.1%), galactose (1.43%), and galacturonic acid (0.321%). Immunological experimental results demonstrated that PHP (400 mg/kg) could restore the intestinal immune function of dextran sulfate sodium-induced mice by modulating the balance between Th17 and Treg cells. Specifically, the number of Th17 cells was reduced, while the number of Treg cells was increased [23]. The polysaccharide EPS is predominantly composed of glucose, accounting for approximately 99% of its structure. Characterization of the chain conformation of EPS revealed that it has a linear backbone of (1→3)-β-D-Glcp residues, featuring a single (1→6)-β-D-Glcp side-branching unit for every three β-D-Glcp residues. Immunological experimental results demonstrated that EPS (20 mg/kg) could increase the thymus and spleen indices and stimulate the release of TNF-α and INF-γ in cyclophosphamide-induced immunosuppressed mice [31].

3. Immunomodulatory Activity of Polysaccharides from Cordyceps militaris

Cordyceps militaris exhibits similar chemical capacities and medicinal functions to Cordyceps sinensis, but is more cost-effective, positioning it as the most viable substitute for Cordyceps sinensis. Therefore, within the Cordyceps genus, Cordyceps militaris enjoys a high degree of commercialization and research interest, second only to Cordyceps sinensis [74]. As primary active ingredients of Cordyceps militaris, polysaccharides have naturally garnered increasing attention due to their immunomodulatory activity. The processes of extraction, purification, and structural characterization of Cordyceps militaris polysaccharides closely resemble those of Cordyceps sinensis polysaccharides. Extraction methods encompass hot water extraction, subcritical water extraction, ultra-high-pressure extraction, microwave extraction, and ultrasonic extraction [75]. Purification methods involve anion exchange chromatography, gel filtration chromatography, and affinity chromatography. Chemical structure characterization encompasses methylation analysis, infrared spectroscopy, gas chromatography–mass spectrometry, and high-performance liquid chromatography [76]. To date, in addition to the polysaccharide fraction, 16 pure polysaccharides with immunomodulatory activity have been purified from Cordyceps militaris. Their chemical structures are summarized in Table 1.

3.1. Immunomodulatory Effects of Intracellular Polysaccharides on Immune Cells

Like Cordyceps sinensis intracellular polysaccharides, four pure intracellular polysaccharides isolated from Cordyceps militaris were demonstrated to exhibit immunomodulatory effects on macrophages, namely, CP2-S, CMP-Fr-II, CMP-III, and SDQCP-1. The polysaccharide CP2-S has a molecular weight of 1.328 kDa and is mainly composed of glucose. It (50–500 μg/mL) has been observed to stimulate phagocytosis, respiratory burst activity, and the secretion of NO, IL-1β, and IL-2 in RAW264.7 cells [24]. CMP-Fr-II is a water-soluble polysaccharide with a molecular weight of 126 kDa. The monosaccharide composition includes glucose, galactose, and mannose with a molar ratio of 56.4:26.4:17.2. It consists of (1→4) or (1→2)-linked Glcp or Galp residues with a (1→2) or (1→6)-linked Manp, Glcp, or Galp residue as a side chain. Immunological experimental results demonstrated that CMP-Fr-II (1000 µg/mL) upregulated the phenotypic functions of RAW264.7 cells and increased NO, TNF-α, and IL-1β production [42]. The molecular weight of the polysaccharide CMP-III is 49.76 kDa. Its monosaccharide composition includes glucose, mannose, and galactose with a molar ratio of 8.09:1.00:0.25. The main linkage types consist of (1→4)-α-D-Glc, (1→4,6)-α-D-Man, (1→)-α-D-Man, and (1→2,6)-α-D-Gal. Immunological experimental results demonstrated that CMP-III (50–500 μg/mL) enhanced phagocytosis and induced the production of NO, TNF-α, and IL-6 in RAW264.7 cells by activating the MAPK and NF-κB signaling pathways [45]. The molecular weight of the polysaccharide SDQCP-1 is 49.76 kDa. The monosaccharide composition includes mannose, glucose, and galactose in a molar ratio of 13.3:1.0:9.7. The backbone is composed of (1→2)-α-D-Manp and (1→4)-β-D-Glcp residues. Its side chains branch at the O-6 position of (1→2)-α-D-Manp, mainly via (1→2)-β-D-Galf or (1→6)-α-D-Manp residues, which are terminated mainly with α-D-Galf and α-D-Galp residues. Immunological experimental results demonstrated that SDQCP-1 (50−250 µg/mL) induced M1 polarization of RAW 264.7 cells and stimulated the release of NO, TNF-α, IL-6, and IL-10 [46]. In summary, Cordyceps militaris polysaccharides exhibit regulatory effects on macrophages that are akin to those of Cordyceps sinensis polysaccharides, encompassing the activation of the MAPK and NF-κB signaling pathways, augmentation of immune factor release, and enhancement of phagocytic activity.
The THP-1 cell line is a human monocytic cell line that was originally isolated and established from the peripheral blood of patients with acute monocytic leukemia. It can be induced to differentiate into macrophages through appropriate stimulation [77]. Lin et al. discovered that the Cordyceps militaris polysaccharide fraction (50−250 µg/mL) reduced apoptosis in THP-1 monocytes induced by aflatoxin while promoting proliferation. Furthermore, it enhanced the expression of immunoregulatory cytokines, including IL-1β, TNF-α, IFN-γ, and IL-6 [78]. The polysaccharide SD-PK5, a linear β-(1→3)-D-glucan, demonstrated the ability to stimulate THP-1 macrophages to express IL-1β, TNF-α, and cyclooxygenase-2 (COX-2) within the concentration range of 10 to 250 µg/mL [50]. The APS is an acidic polysaccharide with a molecular weight of 576 kDa. The monosaccharide composition includes galactose (58.3%), arabinose (27.8%), xylose (7.5%), and rhamnose (6.4%). It is mainly composed of residues such as Araf-(1→, →5)-Araf-(1→, →4)-Galp-(1→, and →4)-GalAp-(1→ residues. Immunological experimental results demonstrated that APSs (1–100 μg/mL) induced alterations in the morphological characteristics of THP-1 monocytes, promoting their differentiation into macrophages. Additionally, APS stimulation resulted in increased phagocytic activity and elevated expression levels of TNF-α, IL-12 p40, IL-8, TLR-2, and TLR-4 [79]. These studies demonstrate that Cordyceps militaris polysaccharides are capable of inducing the differentiation of monocytes into macrophages, augmenting their phagocytic activity, and stimulating the expression of immune factors.
In addition to activating macrophages, research shows that the Cordyceps militaris polysaccharide can promote the immune activity of lymphocytes. The polysaccharide CMPB90-1 is a heteropolysaccharide with a molecular weight of 5.8 kDa. The monosaccharide composition includes galactose, glucose, and mannose with a molar ratio of 3.04:1.00:1.45. The backbone is composed of (1→6)-linked α-d-Glcp and (1→3)-linked α-d-Glcp residues, with branching at O-6, consisting of (1→4)-linked β-d-Manp and (1→6)-linked α-d-Glcp residues, respectively. Immunological experimental results revealed that CMPB90-1 (250–500 μg/mL) demonstrated the ability to stimulate the proliferation of mouse spleen lymphocytes, augment the cytotoxicity of mouse natural killer cells, and enhance the secretion of IL-2 by mouse lymphocytes. Additionally, CMPB90-1 induced an upregulation in T-cell subsets, as evidenced by an increased CD4+/CD8+ T lymphocyte ratio [43]. Wu et al. isolated two acidic polysaccharides, namely, CM-jd(Y)-CPS2 and CM-jd-CPS2, from Cordyceps militaris. Both CM-jd(Y)-CPS2 and CM-jd-CPS2 exhibited a proliferative effect on mouse splenocytes. Moreover, they synergistically enhanced the maturation of mouse T lymphocytes and B lymphocytes induced by concanavalin A and lipopolysaccharides. Notably, CM-jd(Y)-CPS2 demonstrated a more robust stimulatory activity compared to CM-jd-CPS2. The authors inferred that this discrepancy arose from the distinctive structural features of CM-jd-CPS2, characterized by sulfation and the presence of an acetylamino group, in contrast to CM-jd(Y)-CPS2, which is a carboxylated polysaccharide. Consequently, CM-jd(Y)-CPS2 exhibited enhanced capability in establishing associations with target biomolecules through electronic interactions [49]. This indicates that the structure of the Cordyceps polysaccharide influences its immune activity.

3.2. Immunomodulatory Effects of Intracellular Polysaccharides in Animal Models

The latest research indicates that Cordyceps militaris polysaccharides demonstrate immunomodulatory effects across diverse animal models. These effects encompass ameliorating immune suppression induced by cyclophosphamide, restraining allergic reactions, bolstering the body’s antiviral immunity, and counteracting the immunosuppressive tumor microenvironment.
Zhu et al. observed that a polysaccharide-rich extract from Cordyceps militaris (50–200 mg/kg) demonstrated the ability to enhance the spleen and thymus indices, boost splenic lymphocyte activity, strengthen macrophage function, and induce IL-2, IL-4, and IFN-γ production in cyclophosphamide-induced mice [80,81]. Wang et al. additionally demonstrated that the Cordyceps militaris polysaccharide fraction (17.5–70 mg/kg) could counteract cyclophosphamide-induced immunosuppression in mice. This was manifested by an increase in both spleen and thymus indices, along with the augmentation of spleen lymphocyte activity and macrophage function [82].
Ohta et al. reported that APSs (2–8 mg/mL) demonstrated the capacity to elevate levels of TNF-α and IFN-γ in mice infected with the influenza A virus. Additionally, APSs were observed to diminish virus titers in bronchoalveolar lavage fluid and lungs of infected mice, leading to an enhancement in mouse survival rates [39]. The Cordyceps militaris polysaccharide fraction (2–8 mg/mL) also demonstrated the capability to stimulate lymphocyte proliferation, boost serum antibody titers, and elevate concentrations of serum IFN-γ and IL-4 in chickens vaccinated with the Newcastle disease vaccine [83]. This observation indicates that Cordyceps militaris polysaccharides have the potential to enhance the immune response elicited by the Newcastle disease vaccine, suggesting their candidacy as a promising new immune adjuvant.
The polysaccharide CMPB90-1 (50–200 mg/kg) could reverse the immunosuppressive tumor microenvironment in Lewis lung carcinoma tumor-bearing mice. This reversal was achieved by reprogramming tumor-associated macrophages, shifting them from a tumor-promoting M2 phenotype to a tumor-killing M1 phenotype. Specifically, this process reversed the functional inhibition of T lymphocytes by inhibiting the programmed death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) axis between tumor-associated macrophages and T lymphocytes [84]. Zhong et al. reported that a selenium-rich proteoglycan extract from Cordyceps militaris (100–200 mg/kg) boosted immune function and hindered tumor growth by increasing lymphocyte transformation rate, enhancing macrophage clearance, and elevating the spleen index in ascites tumor-bearing mice [85].
In ovalbumin-induced asthmatic mice, the Cordyceps militaris polysaccharide fraction (25–100 mg/kg) suppressed the secretion of eotaxin, IL-4, IL-5, IL-13, and IFN-γ in both blood and bronchoalveolar lavage fluid. Furthermore, it decreased serum IgE levels by inhibiting the activation of the TGF-β/Smad pathway [40,86]. These findings suggest that Cordyceps militaris polysaccharides may hold promise as potential therapeutic agents for treating allergic asthma.

3.3. Immunomodulatory Effects of Extracellular Polysaccharides

Current research has identified three pure extracellular polysaccharides from Cordyceps militaris with immunomodulatory effects, namely, PLCM, EPS-III, and AESP-II. PLCM is a 1,6-branched glucogalactomannan with a molecular weight of 36 kDa. Results from immunological experiments demonstrated that PLCM (10–200 μg/mL) enhanced phagocytic activity and increased the secretion of NO, IL-6, and TNF-α in RAW264.7 cells by activating the MAPK and NF-κB signaling pathways [37]. EPS-III is a neutral polysaccharide with a molecular weight of 1.56 kDa. Its monosaccharide composition includes mannose, glucose, and galactose with a molar ratio of 1.68:1:1.83. The backbone consists of →4)-α-D-Galp-(1→, while →3,6)-α-D-Manp-(1→, →4)-α-D-Manp-(1→, and →3)-β-D-Galp-(1→ are distributed in the backbone or in the branch chains. Immunological experiment results revealed that EPS-III (225 mg/kg) could safeguard the immune organs of streptozotocin-induced diabetic mice from damage induced by high glucose, leading to an enhancement in the spleen index [44]. AESP-II is an acidic pyranose with a molecular weight of 61.52 kDa. Its monosaccharide composition includes mannose, glucuronic acid, rhamnose, galactose acid, N-acetyl-galactosamine, glucose, galactose, and arabinose with a molar ratio of 1.07:5.38:1:3.14:2.23:15:6.09:4.04. Immunological experiment results revealed that AESP-II (25–100 mg/kg) enhanced the proliferation of splenic T and B lymphocytes, raised the levels of IL-2, IL-4, and IFN-γ secreted by T lymphocytes; and increased the levels of immunoglobulins (IgG, IgM, and IgA) secreted by B lymphocytes in cyclophosphamide-induced immunocompromised mice. These effects were achieved through the activation of the p38, ERK, and JNK signaling pathways [47]. These studies demonstrate that the immunoregulatory role of Cordyceps militaris exopolysaccharides primarily involves enhancing the activity of macrophages and lymphocytes, as well as promoting the expression of immune factors.

4. The Immunomodulatory Effects of Cordyceps cicadae Polysaccharides

Cordyceps cicadae is an entomogenous fungus belonging to the Clavicipitaceae family and the genus Cordyceps. It primarily grows inside the nymphs of cicadas and has been utilized for centuries as both food and traditional medicine to address and alleviate a variety of health conditions [87]. JCH-1, JCH-2, IPS1, IPS2, and CP80-1 are five intracellular polysaccharides extracted from Cordyceps cicadae. Chemical structure characterization revealed that IPS1 has a molecular weight of 2400 kDa. Its monosaccharide composition comprises mannose, glucose, and galactose with a molar ratio of 1.35:6.93:1.0. The backbone consists of →4)-α-D-Glcp (1→ and →3,4)-α-D-Manp (1→ residues with a side chain consisting of T-α-D-Galp. IPS2 has a molecular weight of 697 kDa, and its monosaccharide composition comprises mannose, glucose, and galactose with a molar ratio of 2.04:1.0:1.87. The backbone consists of →4)-α-D-Glcp-(1→, →3,4)-α-D-Manp-(1→, and →2,6)-α-D-Manp-(1→ residues, with branches also consisting of T-α-D-Galp [51]. CP80-1 has a molecular weight of 25.461 kDa, and its monosaccharide composition comprises glucose, xylose, and rhamnose with a molar ratio of 19.04:8.73:1.00 [53]. The molecular weight of JCH-1 is 30.9 kDa, and its monosaccharide composition includes glucose, mannose, and galactose with a molar ratio of 1.70:1.37:1.00. JCH-2 has a molecular weight of 555.3 kDa, and its monosaccharide composition comprises glucose, mannose, and galactose with a molar ratio of 5.41:1.04:1.00 [52]. Immunological experiment results demonstrated that these polysaccharides could augment the activity of RAW264.7 macrophages, elevate phagocytosis, and induce the expression of NO and cytokines IL-6, TNF-α, and IL-1β by activating the NF-κB signaling pathway [80,81,82].
Furthermore, the exopolysaccharides of Cordyceps cicadae have been verified to exhibit immunomodulatory activity. Cheng et al. discovered that the Cordyceps cicadae exopolysaccharide fraction (12.5–100 μg/mL) could stimulate the proliferation of RAW264.7 cells and enhance NO production [88]. Kim et al. also discovered that the Cordyceps cicadae exopolysaccharide fraction (10–100 μg/mL) could stimulate the activity of mouse primary macrophages. This stimulation involved binding to membrane receptors such as TLR4, activating MAPK and NF-κB signaling, and increasing the production of NO, IL-1β, TNF-α, and IL-6 [89]. Kim et al. observed that the Cordyceps cicadae exopolysaccharide fraction (10–100 mg/mL), in addition to its immunomodulatory effects on macrophages, could promote mouse dendritic cell maturation. This enhancement was manifested by an increase in the expression of MHC-I, MHC-II, CD80, and CD86; a reduction in endocytosis; heightened cytokine production; and an increased capacity to induce allogeneic T-cell activation [85].

5. Immunomodulatory Effects of Polysaccharides from Other Cordyceps Species

5.1. The Cordyceps kyushuensis Polysaccharide

Cordyceps kyushuensis is the sole species of Cordyceps that grows on the larvae of Cianis bilineata Walker [90]. Su et al. extracted four pure polysaccharides, namely, CKPS-1, CKPS-2, CKPS-3, and CKPS-4, from Cordyceps kyushuensis. Their molecular weights are 7153, 5945, 5643, and 5642 kDa, respectively. The monosaccharide composition of CKPS-1 includes fructose, mannose, glucose, and galactose with a molar ratio of 1:0.92:1.09:0.72. CKPS-2, CKPS-3, and CKPS-4 consist of fructose, mannose, and galactose with molar ratios of 1:0.63:0.61, 1:1.65:1.4, and 1:2.06:1.97, respectively. Immunological experiments demonstrated that CKPS-1, CKPS-2, CKPS-3, and CKPS-4 (62.5–500 μg/mL) all induced the proliferation of mouse splenocytes, enhanced the phagocytic capacity of peritoneal macrophages, and elevated IL-2 and TNF-α expression levels [54].

5.2. The Cordyceps gunnii Polysaccharide

Cordyceps gunnii Berk., initially named after a specimen found in Tasmania, Australia, is frequently reported in China as an adulterant of the Cordyceps sinensis [91]. Meng et al. discovered that the Cordyceps gunnii polysaccharide fraction (125–500 mg/kg) could elevate the spleen and thymus indices, boost natural killer cell toxicity and lymphocyte proliferation activity, and expedite the recovery of peripheral blood white blood cells, red blood cells, hemoglobin, and platelets in cyclophosphamide-induced immunodeficient mice. Additionally, they observed an upregulation of serum IL-2, IL-12, IFN-γ, and IgG levels, along with a reduction in TGF-β levels. These effects were attributed to the activation of the TLR4/NF-κB signaling pathway [92]. Moreover, the Cordyceps gunnii polysaccharide fraction (50–200 mg/kg) could elevate the thymus and spleen indices, enhance macrophage phagocytosis capacity, stimulate splenocyte proliferation, and increase the expression of IFN-γ and TNF-α in H22 tumor-bearing mice. These effects contributed to the inhibition of cancer cell growth [93].

5.3. The Cordyceps taii Polysaccharide

Cordyceps taii is an entomogenous fungus native to South China [94], from which two pure polysaccharides with immunomodulatory effects, PCT-1 and CTP, are extracted. Preliminary chemical structure characterization revealed that the PCT-1 monosaccharide composition includes glucose, mannose, and galactose in a molar ratio of 5.06:4.21:1.00. In a mouse model of D-galactose-induced aging, PCT-1 (100–400 mg/kg) demonstrated the ability to enhance the proliferation of mouse T and B lymphocytes, along with an increase in IgG expression [55]. Preliminary chemical structure characterization revealed that CTP comprises glucose, galactose, and mannose with a molar ratio of 1.14:1.00:1.66 and features a series of α-(1,4) glucosidic bonds. Immunological experiment results demonstrated that the thymus index of streptozotocin-induced diabetic rats increased after treatment with CTP (400 mg/kg). It was speculated that CTP might function as an immunomodulator, potentially restoring thymus weight and enhancing the immune function of pancreatic β cells [95].

5.4. The Cordyceps sobolifera Polysaccharide

Cordyceps sobolifera parasitizes on wingless cicada nymphs, and there are currently few reports on this species [96]. The results of immunological experiments indicated that the selenium-rich extracellular polysaccharide fraction (50–200 mg/kg) could enhance the immune organ index, increase serum cytokine IL-2 and TNF-α levels, and elevate the ratio of CD8+/CD4+ T lymphocytes in colon cancer tumor-bearing mice. These effects contributed to the inhibition of tumor growth [97].

6. Conclusions and Perspectives

In summary, these studies demonstrate the substantial immunomodulatory effects of Cordyceps polysaccharides, suggesting their potential application in the treatment and amelioration of diverse diseases (Table 2).
These polysaccharides primarily originate from the widely discussed Cordyceps sinensis and Cordyceps militaris. These encompass intracellular polysaccharides extracted from fruiting bodies or mycelium, as well as extracellular polysaccharides obtained from the fermentation broth of artificially cultivated Cordyceps. Several studies have indicated that polysaccharides derived from Cordyceps cicadae, Cordyceps kyushuensis, Cordyceps gunnii, Cordyceps taii, and Cordyceps sobolifera also exhibit immunomodulatory activity. However, the number of such studies is still limited. The immunological experiment results indicate that Cordyceps polysaccharides have the capacity to stimulate phenotype switching and differentiation of macrophages, augment phagocytic activity, and activate the MAPK and NF-κB signaling pathways, thereby inducing the expression of various immunoactive substances such as NO, IL-1β, IL-6, IL-10, TNF-α, MCP-1, and MIP-1α (Figure 1). Furthermore, Cordyceps polysaccharides demonstrate the ability to induce the proliferation and activation of lymphocytes. This is achieved through the upregulation of MHC-II, CD40, CD80, and CD86 expression, as well as the induction of the expression of immunoactive substances such as IL-2, IL-12, IFN-γ, TNF-α, IL-4, IL-10, and GATA-3. Cordyceps polysaccharides have also been observed to promote the maturation and activation of dendritic cells, enhancing their capacity to uptake antigens and stimulate lymphocyte proliferation. Animal experiments have provided additional confirmation of the immunomodulatory effects of Cordyceps polysaccharides. Cordyceps polysaccharides have the capacity to ameliorate immune suppression induced by cyclophosphamide or radiation, reverse immune evasion prompted by tumors, and bolster the body’s antiviral capabilities.
While current research indicates immunomodulatory effects of Cordyceps polysaccharides, there remain certain issues that warrant further exploration. There is a limited number of studies investigating the connection between polysaccharide structure and immunomodulatory activity, despite the comprehensive exploration of the immunomodulatory effects of Cordyceps polysaccharides in current research. Given the close correlation between polysaccharide structure and its activity, it is of paramount significance to delve deeper into understanding the relationship between polysaccharide structure and immune activity. Secondly, current research predominantly focuses on investigating the immunomodulatory activity of Cordyceps polysaccharides, specifically their effect on macrophages and lymphocytes. However, there is a paucity of studies concerning other vital immune cells, such as dendritic cells and natural killer cells. There is also a need for in-depth exploration of additional mechanisms involved in immune regulation. Thirdly, the current research predominantly emphasizes cell experiments and animal studies. There is consequently a demand for additional clinical investigations to confirm the immunomodulatory effects of Cordyceps polysaccharides.

Author Contributions

L.C.: resources, methodology, writing—original draft, writing—review and editing, supervision. X.L.: methodology, review and editing, supervision. K.Z.: review and editing. Y.W.: review and editing. M.L.: review and editing. Y.Z.: review and editing. Y.C.: review and editing. S.D.: review. S.L.: editing. G.Z.: editing. L.L.: review and editing, supervision. Y.H.: review and editing, supervision. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Sichuan Traditional Chinese Medicine Health Industry Development and Rural Revitalization Research Center Project: DJKYB202321; the Xihua University Talent Introduction Project: Z241026; the Open Research Fund of Chengdu University of Traditional Chinese Medicine State Key Laboratory of Southwestern Chinese Medicine Resources: SKLTCM2022013; the Key Research and Development Project of Liangshan Prefecture: 23ZDYF0177; and the Xihua University Postgraduate Scientific Innovation Competition: YK20240252.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors state that there are no conflicts of interest.

References

  1. Zheng, P.; Xia, Y.L.; Zhang, S.W.; Wang, C.S. Genetics of Cordyceps and related fungi. Appl. Microbiol. Biotechnol. 2013, 97, 2797–2804. [Google Scholar] [CrossRef] [PubMed]
  2. Olatunji, O.J.; Tang, J.; Tola, A.; Auberon, F.; Oluwaniyi, O.; Ouyang, Z. The genus Cordyceps: An extensive review of its traditional uses, phytochemistry and pharmacology. Fitoterapia 2018, 129, 293–316. [Google Scholar] [CrossRef] [PubMed]
  3. Nxumalo, W.; Elateeq, A.A.; Sun, Y.F. Can Cordyceps cicadae be used as an alternative to Cordyceps militaris and Cordyceps sinensis?—A review. J. Ethnopharmacol. 2020, 257, 112879. [Google Scholar] [CrossRef]
  4. Shashidhar, M.G.; Giridhar, P.; Sankar, K.U.; Manohar, B. Bioactive principles from Cordyceps sinensis: A potent food supplement—A review. J. Funct. Foods 2013, 5, 1013–1030. [Google Scholar] [CrossRef]
  5. Jedrejko, K.J.; Lazur, J.; Muszynska, B. Cordyceps militaris: An Overview of Its Chemical Constituents in Relation to Biological Activity. Foods 2021, 10, 2643. [Google Scholar] [CrossRef]
  6. Yue, K.; Ye, M.; Zhou, Z.J.; Sun, W.; Lin, X. The genus Cordyceps: A chemical and pharmacological review. J. Pharm. Pharmacol. 2013, 65, 474–493. [Google Scholar] [CrossRef]
  7. Krishna, K.V.; Ulhas, R.S.; Malaviya, A. Bioactive compounds from Cordyceps and their therapeutic potential. Crit. Rev. Biotechnol. 2023, 44, 753–773. [Google Scholar] [CrossRef]
  8. Das, G.; Shin, H.S.; Leyva-Gomez, G.; Del Prado-Audelo, M.L.; Cortes, H.; Singh, Y.D.; Panda, M.K.; Mishra, A.P.; Nigam, M.; Saklani, S.; et al. Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials. Front. Pharmacol. 2021, 11, 602364. [Google Scholar] [CrossRef]
  9. Yan, J.K.; Wang, W.Q.; Wu, J.Y. Recent advances in Cordyceps sinensis polysaccharides: Mycelial fermentation, isolation, structure, and bioactivities: A review. J. Funct. Foods 2014, 6, 33–47. [Google Scholar] [CrossRef]
  10. Wang, W.L.; Tan, J.Q.; Nima, L.M.; Sang, Y.M.; Cai, X.; Xue, H.K. Polysaccharides from fungi: A review on their extraction, purification, structural features, and biological activities. Food Chem. X 2022, 15, 100414. [Google Scholar] [CrossRef]
  11. Kuo, M.C.; Chang, C.Y.; Cheng, T.L.; Wu, M.J. Immunomodulatory effect of exo-polysaccharides from submerged cultured Cordyceps sinensis: Enhancement of cytokine synthesis, CD11b expression, and phagocytosis. Appl. Microbiol. Biotechnol. 2007, 75, 769–775. [Google Scholar] [CrossRef] [PubMed]
  12. Ding, X.; Song, Z.Q.; Hou, Y.L. Comparative study on the structure characterization and immune activity of Lactarius vellereus Fr. polysaccharide (LV-1) and Cordyceps militaris (L. ex Fr.) Link. polysaccharide (CM-S). J. Food Meas. Charact. 2022, 16, 901–919. [Google Scholar] [CrossRef]
  13. Lee, J.S.; Hong, E.K. Immunostimulating activity of the polysaccharides isolated from Cordyceps militaris. Int. Immunopharmacol. 2011, 11, 1226–1233. [Google Scholar] [CrossRef] [PubMed]
  14. Wei, Y.; Du, X.; Guo, Y.; Chang, M.; Deng, B.; Liu, J.; Cao, J. Elucidation of physicochemical properties of polysaccharides extracted from Cordyceps militaris fruiting bodies with different drying treatments and their effects on ulcerative colitis in zebrafish. Front. Nutr. 2022, 9, 980357. [Google Scholar] [CrossRef]
  15. Sun, Y.X.; Rabbi, M.H.; Ma, S.H.; Wen, Z.X.; Li, X.J.; Mi, R.; Meng, N.; Li, Y.J.; Wang, Q.Z.; Du, X.F.; et al. Effect of dietary Cordyceps polysaccharide supplementation on intestinal microflora and immune response of Apostichopus japonicus. Aquac. Res. 2021, 52, 5198–5212. [Google Scholar] [CrossRef]
  16. Liu, B.; Ding, D.; Zhao, P.; Zhang, X.G.; Tian, Z.J.; Xia, X.X.; Zhang, Z.H. Evaluation of Immune Function of Mycelium Fermentation of Hirsutella sinensisin In Vitro and In Vivo. Nanosci. Nanotechnol. Lett. 2020, 12, 1337–1343. [Google Scholar] [CrossRef]
  17. Deng, B.; Wang, Z.P.; Tao, W.J.; Li, W.F.; Wang, C.; Wang, M.Q.; Ye, S.S.; Du, Y.J.; Wu, X.X.; Wu, D. Effects of polysaccharides from mycelia of Cordyceps sinensis on growth performance, immunity and antioxidant indicators of the white shrimp Litopenaeus vannamei. Aquac. Nutr. 2015, 21, 173–179. [Google Scholar] [CrossRef]
  18. Kang, S.; Nie, L.X.; Zheng, Y.G.; Zuo, T.T.; Wang, Y.; Shi, J.; Ma, S.C. Micro-morphological identification study on Cordyceps sinensis (Berk.) Sacc. and its adulterants based on stereo microscope and desktop scanning electron microscope. Microsc. Res. Tech. 2021, 84, 1936–1946. [Google Scholar] [CrossRef]
  19. Yuan, Q.H.; Xie, F.; Tan, J.; Yuan, Y.; Mei, H.; Zheng, Y.; Sheng, R. Extraction, structure and pharmacological effects of the polysaccharides from Cordyceps sinensis: A review. J. Funct. Foods 2022, 89, 104909. [Google Scholar] [CrossRef]
  20. Yan, J.K.; Wang, W.Q.; Li, L.; Wu, J.Y. Physiochemical properties and antitumor activities of two α-glucans isolated from hot water and alkaline extracts of Cordyceps (Cs-HK1) fungal mycelia. Carbohydr. Polym. 2011, 85, 753–758. [Google Scholar] [CrossRef]
  21. Shashidhar, G.M.; Giridhar, P.; Manohar, B. Functional polysaccharides from medicinal mushroom Cordyceps sinensis as a potent food supplement: Extraction, characterization and therapeutic potentials—A systematic review. RSC Adv. 2015, 5, 16050–16066. [Google Scholar] [CrossRef]
  22. Tan, L.; Liu, S.; Li, X.; He, J.; He, L.; Li, Y.; Yang, C.; Li, Y.; Hua, Y.; Guo, J. The Large Molecular Weight Polysaccharide from Wild Cordyceps and Its Antitumor Activity on H22 Tumor-Bearing Mice. Molecules 2023, 28, 3351. [Google Scholar] [CrossRef] [PubMed]
  23. Cui, L.; He, N.; Yu, S.; Pang, H.; Zhang, Z.; Wang, J.; Hao, J.; Li, S. Polysaccharides from Paecilomyces hepiali Prevent Acute Colitis in Association with Modulating Gut Microbiota and Treg/Th17 Immune Balance in Mice. Molecules 2023, 28, 4984. [Google Scholar] [CrossRef] [PubMed]
  24. Zhu, L.; Tang, Q.; Zhou, S.; Liu, Y.; Zhang, Z.; Gao, X.; Wang, S.; Wang, Z. Isolation and purification of a polysaccharide from the caterpillar medicinal mushroom Cordyceps militaris (Ascomycetes) fruit bodies and its immunomodulation of RAW 264.7 macrophages. Int. J. Med. Mushrooms 2014, 16, 247–257. [Google Scholar] [CrossRef] [PubMed]
  25. Liu, Y.; Li, Q.Z.; Li, L.D.; Zhou, X.W. Immunostimulatory effects of the intracellular polysaccharides isolated from liquid culture of Ophiocordyceps sinensis (Ascomycetes) on RAW264.7 cells via the MAPK and PI3K/Akt signaling pathways. J. Ethnopharmacol. 2021, 275, 114130. [Google Scholar] [CrossRef]
  26. Wu, D.T.; Meng, L.Z.; Wang, L.Y.; Lv, G.P.; Cheong, K.L.; Hu, D.J.; Guan, J.; Zhao, J.; Li, S.P. Chain conformation and immunomodulatory activity of a hyperbranched polysaccharide from Cordyceps sinensis. Carbohydr. Polym. 2014, 110, 405–414. [Google Scholar] [CrossRef]
  27. Cheong, K.L.; Meng, L.Z.; Chen, X.Q.; Wang, L.Y.; Wu, D.T.; Zhao, J.; Li, S.P. Structural elucidation, chain conformation and immuno-modulatory activity of glucogalactomannan from cultured Cordyceps sinensis fungus UM01. J. Funct. Foods 2016, 25, 174–185. [Google Scholar] [CrossRef]
  28. Zhang, J.; Yu, Y.; Zhang, Z.; Ding, Y.; Dai, X.; Li, Y. Effect of polysaccharide from cultured Cordyceps sinensis on immune function and anti-oxidation activity of mice exposed to 60Co. Int. Immunopharmacol. 2011, 11, 2251–2257. [Google Scholar] [CrossRef]
  29. Wang, Z.M.; Peng, X.A.; Lee, K.L.D.; Tang, J.C.O.; Cheung, P.C.K.; Wu, J.Y. Structural characterisation and immunomodulatory property of an acidic polysaccharide from mycelial culture of Cordyceps sinensis fungus Cs-HK1. Food Chem. 2011, 125, 637–643. [Google Scholar] [CrossRef]
  30. Sheng, L.; Chen, J.; Li, J.; Zhang, W. An exopolysaccharide from cultivated Cordyceps sinensis and its effects on cytokine expressions of immunocytes. Appl. Biochem. Biotechnol. 2011, 163, 669–678. [Google Scholar] [CrossRef]
  31. Hu, T.; Jiang, C.; Huang, Q.; Sun, F. A comb-like branched β-D-glucan produced by a Cordyceps sinensis fungus and its protective effect against cyclophosphamide-induced immunosuppression in mice. Carbohydr. Polym. 2016, 142, 259–267. [Google Scholar] [CrossRef] [PubMed]
  32. Rong, L.; Li, G.; Zhang, Y.; Xiao, Y.; Qiao, Y.; Yang, M.; Wei, L.; Bi, H.; Gao, T. Structure and immunomodulatory activity of a water-soluble α-glucan from Hirsutella sinensis mycelia. Int. J. Biol. Macromol. 2021, 189, 857–868. [Google Scholar] [CrossRef] [PubMed]
  33. He, L.; Ji, P.; Cheng, J.; Wang, Y.; Qian, H.; Li, W.; Gong, X.; Wang, Z. Structural characterization and immunostimulatory activity of a novel protein-bound polysaccharide produced by Hirsutella sinensis Liu, Guo, Yu & Zeng. Food Chem. 2013, 141, 946–953. [Google Scholar] [CrossRef] [PubMed]
  34. Wang, J.Q.; Nie, S.P.; Cui, S.W.; Wang, Z.J.; Phillips, A.O.; Phillips, G.O.; Li, Y.J.; Xie, M.Y. Structural characterization and immunostimulatory activity of a glucan from natural Cordyceps sinensis. Food Hydrocoll. 2017, 67, 139–147. [Google Scholar] [CrossRef]
  35. Wu, Y.; Sun, H.; Qin, F.; Pan, Y.; Sun, C. Effect of various extracts and a polysaccharide from the edible mycelia of Cordyceps sinensis on cellular and humoral immune response against ovalbumin in mice. Phytother. Res. PTR 2006, 20, 646–652. [Google Scholar] [CrossRef]
  36. Cheung, J.K.; Li, J.; Cheung, A.W.; Zhu, Y.; Zheng, K.Y.; Bi, C.W.; Duan, R.; Choi, R.C.; Lau, D.T.; Dong, T.T.; et al. Cordysinocan, a polysaccharide isolated from cultured Cordyceps, activates immune responses in cultured T-lymphocytes and macrophages: Signaling cascade and induction of cytokines. J. Ethnopharmacol. 2009, 124, 61–68. [Google Scholar] [CrossRef]
  37. Lee, J.S.; Kwon, D.S.; Lee, K.R.; Park, J.M.; Ha, S.J.; Hong, E.K. Mechanism of macrophage activation induced by polysaccharide from Cordyceps militaris culture broth. Carbohydr. Polym. 2015, 120, 29–37. [Google Scholar] [CrossRef]
  38. Liu, Y.; Yang, J.; Guo, Z.; Li, Q.; Zhang, L.; Zhao, L.; Zhou, X. Immunomodulatory Effect of Cordyceps militaris Polysaccharide on RAW 264.7 Macrophages by Regulating MAPK Signaling Pathways. Molecules 2024, 29, 3408. [Google Scholar] [CrossRef]
  39. Ohta, Y.; Lee, J.B.; Hayashi, K.; Fujita, A.; Park, D.K.; Hayashi, T. In vivo anti-influenza virus activity of an immunomodulatory acidic polysaccharide isolated from Cordyceps militaris grown on germinated soybeans. J. Agric. Food Chem. 2007, 55, 10194–10199. [Google Scholar] [CrossRef]
  40. Song, L.; Yang, J.; Kong, W.; Liu, Y.; Liu, S.; Su, L. Cordyceps militaris polysaccharide alleviates ovalbumin-induced allergic asthma through the Nrf2/HO-1 and NF-κB signaling pathways and regulates the gut microbiota. Int. J. Biol. Macromol. 2023, 238, 124333. [Google Scholar] [CrossRef]
  41. Luo, X.; Duan, Y.; Yang, W.; Zhang, H.; Li, C.; Zhang, J. Structural elucidation and immunostimulatory activity of polysaccharide isolated by subcritical water extraction from Cordyceps militaris. Carbohydr. Polym. 2017, 157, 794–802. [Google Scholar] [CrossRef] [PubMed]
  42. Lee, J.S.; Kwon, J.S.; Won, D.P.; Lee, J.H.; Lee, K.E.; Lee, S.Y.; Hong, E.K. Study of macrophage activation and structural characteristics of purified polysaccharide from the fruiting body of Cordyceps militaris. J. Microbiol. Biotechnol. 2010, 20, 1053–1060. [Google Scholar] [CrossRef] [PubMed]
  43. Bi, S.; Jing, Y.; Zhou, Q.; Hu, X.; Zhu, J.; Guo, Z.; Song, L.; Yu, R. Structural elucidation and immunostimulatory activity of a new polysaccharide from Cordyceps militaris. Food Funct. 2018, 9, 279–293. [Google Scholar] [CrossRef] [PubMed]
  44. Sun, H.; Yu, X.; Li, T.; Zhu, Z. Structure and hypoglycemic activity of a novel exopolysaccharide of Cordyceps militaris. Int. J. Biol. Macromol. 2021, 166, 496–508. [Google Scholar] [CrossRef]
  45. He, B.L.; Zheng, Q.W.; Guo, L.Q.; Huang, J.Y.; Yun, F.; Huang, S.S.; Lin, J.F. Structural characterization and immune-enhancing activity of a novel high-molecular-weight polysaccharide from Cordyceps militaris. Int. J. Biol. Macromol. 2020, 145, 11–20. [Google Scholar] [CrossRef]
  46. Zhang, Y.; Zeng, Y.; Cui, Y.S.; Liu, H.M.; Dong, C.X.; Sun, Y.X. Structural characterization, antioxidant and immunomodulatory activities of a neutral polysaccharide from Cordyceps militaris cultivated on hull-less barley. Carbohydr. Polym. 2020, 235, 115969. [Google Scholar] [CrossRef]
  47. Yu, Y.; Wen, Q.; Song, A.; Liu, Y.; Wang, F.; Jiang, B. Isolation and immune activity of a new acidic Cordyceps militaris exopolysaccharide. Int. J. Biol. Macromol. 2022, 194, 706–714. [Google Scholar] [CrossRef]
  48. Yu, R.; Song, L.; Zhao, Y.; Bin, W.; Wang, L.; Zhang, H.; Wu, Y.; Ye, W.; Yao, X. Isolation and biological properties of polysaccharide CPS-1 from cultured Cordyceps militaris. Fitoterapia 2004, 75, 465–472. [Google Scholar] [CrossRef]
  49. Wu, F.; Yan, H.; Ma, X.; Jia, J.; Zhang, G.; Guo, X.; Gui, Z. Comparison of the structural characterization and biological activity of acidic polysaccharides from Cordyceps militaris cultured with different media. World J. Microbiol. Biotechnol. 2012, 28, 2029–2038. [Google Scholar] [CrossRef]
  50. Smiderle, F.R.; Baggio, C.H.; Borato, D.G.; Santana-Filho, A.P.; Sassaki, G.L.; Iacomini, M.; Van Griensven, L.J. Anti-inflammatory properties of the medicinal mushroom Cordyceps militaris might be related to its linear (1→3)-β-D-glucan. PLoS ONE 2014, 9, e110266. [Google Scholar] [CrossRef]
  51. Tian, J.; Zhang, C.; Wang, X.; Rui, X.; Zhang, Q.; Chen, X.; Dong, M.; Li, W. Structural characterization and immunomodulatory activity of intracellular polysaccharide from the mycelium of Paecilomyces cicadae TJJ1213. Food Res. Int. 2021, 147, 110515. [Google Scholar] [CrossRef] [PubMed]
  52. Bi, S.X.; Huang, W.J.; Chen, S.; Huang, C.H.; Li, C.L.; Guo, Z.Y.; Yang, J.N.; Zhu, J.H.; Song, L.Y.; Yu, R.M. Cordyceps militaris polysaccharide converts immunosuppressive macrophages into M1-like phenotype and activates T lymphocytes by inhibiting the PD-L1/PD-1 axis between TAMs and T lymphocytes. Int. J. Biol. Macromol. 2020, 150, 261–280. [Google Scholar] [CrossRef] [PubMed]
  53. Xu, Z.; Yan, X.; Song, Z.; Li, W.; Zhao, W.; Ma, H.; Du, J.; Li, S.; Zhang, D. Two heteropolysaccharides from Isaria cicadae Miquel differ in composition and potentially immunomodulatory activity. Int. J. Biol. Macromol. 2018, 117, 610–616. [Google Scholar] [CrossRef] [PubMed]
  54. Wan, J.Q.; Zhu, Y.L.; Jiang, X.; Wang, F.X.; Zhou, Z.Y.; Wang, J.B.; Liu, C.; Wei, Y.; Ouyang, Z. Immunomodulation of RAW264.7 cells by CP80-1, a polysaccharide of Cordyceps cicadae, via Dectin-1/Syk/NF-κB signaling pathway. Food Agric. Immunol. 2023, 34, 2231172. [Google Scholar] [CrossRef]
  55. Su, J.; Sun, J.; Jian, T.; Zhang, G.; Ling, J. Immunomodulatory and Antioxidant Effects of Polysaccharides from the Parasitic Fungus Cordyceps kyushuensis. BioMed Res. Int. 2020, 2020, 8257847. [Google Scholar] [CrossRef]
  56. Xiao, J.H.; Xiao, D.M.; Chen, D.X.; Xiao, Y.; Liang, Z.Q.; Zhong, J.J. Polysaccharides from the Medicinal Mushroom Cordyceps taii Show Antioxidant and Immunoenhancing Activities in a D-Galactose-Induced Aging Mouse Model. Evid.-Based Complement. Altern. Med. Ecam 2012, 2012, 273435. [Google Scholar] [CrossRef]
  57. Xiao, D.M.; Yu, S.; Xiao, J.H. Antioxidant activities of alkali-soluble polysaccharides from medicinal mushroom Cordyceps taii and its chemical characteristics. Biomed. Res.-India 2016, 27, 199–206. [Google Scholar]
  58. Yin, M.; Zhang, Y.; Li, H. Advances in Research on Immunoregulation of Macrophages by Plant Polysaccharides. Front. Immunol. 2019, 10, 145. [Google Scholar] [CrossRef]
  59. Chen, W.; Yuan, F.; Wang, K.; Song, D.; Zhang, W. Modulatory effects of the acid polysaccharide fraction from one of anamorph of Cordyceps sinensis on Ana-1 cells. J. Ethnopharmacol. 2012, 142, 739–745. [Google Scholar] [CrossRef]
  60. Chen, W.; Zhang, W.; Shen, W.; Wang, K. Effects of the acid polysaccharide fraction isolated from a cultivated Cordyceps sinensis on macrophages in vitro. Cell. Immunol. 2010, 262, 69–74. [Google Scholar] [CrossRef]
  61. Meng, L.Z.; Lin, B.Q.; Wang, B.; Feng, K.; Hu, D.J.; Wang, L.Y.; Cheong, K.L.; Zhao, J.; Li, S.P. Mycelia extracts of fungal strains isolated from Cordyceps sinensis differently enhance the function of RAW 264.7 macrophages. J. Ethnopharmacol. 2013, 148, 818–825. [Google Scholar] [CrossRef] [PubMed]
  62. Meng, L.Z.; Feng, K.; Wang, L.Y.; Cheong, K.L.; Nie, H.; Zhao, J.; Li, S.P. Activation of mouse macrophages and dendritic cells induced by polysaccharides from a novel Cordyceps sinensis fungus UM01. J. Funct. Foods 2014, 9, 242–253. [Google Scholar] [CrossRef]
  63. Li, L.F.; But, G.W.; Zhang, Q.W.; Liu, M.; Chen, M.M.; Wen, X.; Wu, H.Y.; Cheng, H.Y.; Puno, P.T.; Zhang, J.X.; et al. A specific and bioactive polysaccharide marker for Cordyceps. Carbohydr. Polym. 2021, 269, 118343. [Google Scholar] [CrossRef]
  64. Hao, T.; Li, J.J.; Du, Z.Y.; Duan, C.M.; Wang, Y.M.; Wang, C.Y.; Song, J.P.; Wang, L.J.; Li, Y.H.; Wang, Y. Cordyceps sinensis enhances lymphocyte proliferation and CD markers expression in simulated microgravity environment. J. Exp. Hematol. 2012, 20, 1212–1215. [Google Scholar]
  65. Takeuchi, A.; Kato, K.; Akashi, K.; Eto, M. Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy. Int. J. Urol. 2018, 25, 112–120. [Google Scholar] [CrossRef] [PubMed]
  66. Fan, S.T.; Nie, S.P.; Huang, X.J.; Wang, S.; Hu, J.L.; Xie, J.H.; Nie, Q.X.; Xie, M.Y. Protective properties of combined fungal polysaccharides from Cordyceps sinensis and Ganoderma atrum on colon immune dysfunction. Int. J. Biol. Macromol. 2018, 114, 1049–1055. [Google Scholar] [CrossRef]
  67. Chen, S.P.; Wang, J.Q.; Fang, Q.Y.; Dong, N.; Nie, S.P. Polysaccharide from natural Cordyceps sinensis ameliorated intestinal injury and enhanced antioxidant activity in immunosuppressed mice. Food Hydrocoll. 2019, 89, 661–667. [Google Scholar] [CrossRef]
  68. Ying, M.; Yu, Q.; Zheng, B.; Wang, H.; Wang, J.; Chen, S.; Nie, S.; Xie, M. Cultured Cordyceps sinensis polysaccharides modulate intestinal mucosal immunity and gut microbiota in cyclophosphamide-treated mice. Carbohydr. Polym. 2020, 235, 115957. [Google Scholar] [CrossRef]
  69. Chen, S.; Wang, J.; Fang, Q.; Dong, N.; Fang, Q.; Cui, S.W.; Nie, S. A polysaccharide from natural Cordyceps sinensis regulates the intestinal immunity and gut microbiota in mice with cyclophosphamide-induced intestinal injury. Food Funct. 2021, 12, 6271–6282. [Google Scholar] [CrossRef]
  70. Yang, J.; Nian, Y.; Duan, Y.; Xin, Y.; Zhu, L.; Liu, G.; Li, X. Protection against X-Ray Irradiation Injury by Chinese Caterpillar Medicinal Mushroom Ophiocordyceps sinensis (Ascomycetes) Polysaccharides in Mice. Int. J. Med. Mushrooms 2020, 22, 815–827. [Google Scholar] [CrossRef]
  71. Yang, S.L.; Yang, X.; Zhang, H. Extracellular polysaccharide biosynthesis in Cordyceps. Crit. Rev. Microbiol. 2020, 46, 359–380. [Google Scholar] [CrossRef] [PubMed]
  72. Hivroz, C.; Chemin, K.; Tourret, M.; Bohineust, A. Crosstalk between T Lymphocytes and Dendritic Cells. Crit. Rev. Immunol. 2012, 32, 139–155. [Google Scholar] [CrossRef] [PubMed]
  73. Song, D.; Lin, J.Y.; Yuan, F.J.; Zhang, W.Y. Ex vivo stimulation of murine dendritic cells by an exopolysaccharide from one of the anamorph of Cordyceps sinensis. Cell Biochem. Funct. 2011, 29, 555–561. [Google Scholar] [CrossRef] [PubMed]
  74. Song, D.; He, Z.; Wang, C.; Yuan, F.; Dong, P.; Zhang, W. Regulation of the exopolysaccharide from an anamorph of Cordyceps sinensis on dendritic cell sarcoma (DCS) cell line. Eur. J. Nutr. 2013, 52, 687–694. [Google Scholar] [CrossRef] [PubMed]
  75. Shrestha, B.; Zhang, W.M.; Zhang, Y.J.; Liu, X.Z. The medicinal fungus Cordyceps militaris: Research and development. Mycol. Prog. 2012, 11, 599–614. [Google Scholar] [CrossRef]
  76. Lee, C.T.; Huang, K.S.; Shaw, J.F.; Chen, J.R.; Kuo, W.S.; Shen, G.X.; Grumezescu, A.M.; Holban, A.M.; Wang, Y.T.; Wang, J.S.; et al. Trends in the Immunomodulatory Effects of Cordyceps militaris: Total Extracts, Polysaccharides and Cordycepin. Front. Pharmacol. 2020, 11, 575704. [Google Scholar] [CrossRef]
  77. Zhang, J.X.; Wen, C.T.; Duan, Y.Q.; Zhang, H.H.; Ma, H.L. Advance in Cordyceps militaris (Linn) Link polysaccharides: Isolation, structure, and bioactivities: A review. Int. J. Biol. Macromol. 2019, 132, 906–914. [Google Scholar] [CrossRef]
  78. Chanput, W.; Mes, J.J.; Wichers, H.J. THP-1 cell line: An in vitro cell model for immune modulation approach. Int. Immunopharmacol. 2014, 23, 37–45. [Google Scholar] [CrossRef]
  79. Lin, R.K.; Choong, C.Y.; Hsu, W.H.; Tai, C.J.; Tai, C.J. Polysaccharides obtained from mycelia of Cordyceps militaris attenuated doxorubicin-induced cytotoxic effects in chemotherapy. Afr. Health Sci. 2019, 19, 2156–2163. [Google Scholar] [CrossRef]
  80. Park, D.K.; Hayashi, T.; Park, H.J. Arabinogalactan-type polysaccharides (APS) from Cordyceps militaris grown on germinated soybeans (GSC) induces innate immune activity of THP-1 monocytes through promoting their macrophage differentiation and macrophage activity. Food Sci. Biotechnol. 2012, 21, 1501–1506. [Google Scholar] [CrossRef]
  81. Zhu, S.J.; Pan, J.; Zhao, B.; Liang, J.; Ze-Yu, W.; Yang, J.J. Comparisons on enhancing the immunity of fresh and dry Cordyceps militaris in vivo and in vitro. J. Ethnopharmacol. 2013, 149, 713–719. [Google Scholar] [CrossRef] [PubMed]
  82. Zhu, S.J.; Pan, J.; Yang, J.J.; Zhou, A. Immune activation and toxicity evaluation of fresh Cordyceps militaris extracts by high-pressure processing. Food Agric. Immunol. 2015, 26, 645–658. [Google Scholar] [CrossRef]
  83. Wang, M.; Meng, X.Y.; Yang, R.L.; Qin, T.; Wang, X.Y.; Zhang, K.Y.; Fei, C.Z.; Li, Y.; Hu, Y.; Xue, F.Q. Cordyceps militaris polysaccharides can enhance the immunity and antioxidation activity in immunosuppressed mice. Carbohydr. Polym. 2012, 89, 461–466. [Google Scholar] [CrossRef] [PubMed]
  84. Wang, M.; Meng, X.; Yang, R.; Qin, T.; Li, Y.; Zhang, L.; Fei, C.; Zhen, W.; Zhang, K.; Wang, X.; et al. Cordyceps militaris polysaccharides can improve the immune efficacy of Newcastle disease vaccine in chicken. Int. J. Biol. Macromol. 2013, 59, 178–183. [Google Scholar] [CrossRef]
  85. Zhong, M.; Wang, L.H.; Ma, H.; Guo, Z.F.; Wang, C.C.; Liu, S.X. Effect of selenium-protein polysaccharide extracted from Se-rich Cordyceps militaris on tumor-bearing mice. China J. Chin. Mater. Medica 2008, 33, 2120–2123. [Google Scholar]
  86. Zheng, Y.; Li, L.; Cai, T. Cordyceps polysaccharide ameliorates airway inflammation in an ovalbumin-induced mouse model of asthma via TGF-β1/Smad signaling pathway. Respir. Physiol. Neurobiol. 2020, 276, 103412. [Google Scholar] [CrossRef]
  87. Xie, X.C.; Guo, H.; Liu, J.; Wang, J.B.; Li, H.H.; Deng, Z.Y. Edible and Medicinal Progress of Cryptotympana atrata (Fabricius) in China. Nutrients 2023, 15, 4266. [Google Scholar] [CrossRef]
  88. Cheng, J.W.; Wang, Y.B.; He, L.; Qian, H.; Fu, L.Z.; Li, H.B. Optimization of fermentation process for the production of intracellular polysaccharide from Paecilomyces cicadae and the immuno-stimulating activity of intracellular polysaccharide. World J. Microbiol. Biotechnol. 2012, 28, 3293–3299. [Google Scholar] [CrossRef]
  89. Kim, H.S.; Kim, Y.J.; Lee, H.K.; Ryu, H.S.; Kim, J.S.; Yoon, M.J.; Kang, J.S.; Hong, J.T.; Kim, Y.; Han, S.B. Activation of macrophages by polysaccharide isolated from Paecilomyces cicadae through toll-like receptor 4. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2012, 50, 3190–3197. [Google Scholar] [CrossRef]
  90. Zhao, X.; Zhang, G.Y.; Li, C.Y.; Ling, J.Y. Cordycepin and pentostatin biosynthesis gene identified through transcriptome and proteomics analysis of Cordyceps kyushuensis Kob. Microbiol. Res. 2019, 218, 12–21. [Google Scholar] [CrossRef]
  91. Chan, W.H.; Ling, K.H.; Chiu, S.W.; Shaw, P.C.; But, P.P.H. Molecular Analyses of Cordyceps gunnii in China. J. Food Drug Anal. 2011, 19, 18–25. [Google Scholar] [CrossRef]
  92. Meng, M.; Wang, H.; Li, Z.; Guo, M.; Hou, L. Protective effects of polysaccharides from Cordyceps gunnii mycelia against cyclophosphamide-induced immunosuppression to TLR4/TRAF6/NF-κB signalling in BALB/c mice. Food Funct. 2019, 10, 3262–3271. [Google Scholar] [CrossRef] [PubMed]
  93. Zhu, Z.Y.; Chen, J.; Si, C.L.; Liu, N.; Lian, H.Y.; Ding, L.N.; Liu, Y.; Zhang, Y.M. Immunomodulatory effect of polysaccharides from submerged cultured Cordyceps gunnii. Pharm. Biol. 2012, 50, 1103–1110. [Google Scholar] [CrossRef] [PubMed]
  94. Liu, R.M.; Zhang, X.J.; Liang, G.Y.; Yang, Y.F.; Zhong, J.J.; Xiao, J.H. Antitumor and antimetastatic activities of chloroform extract of medicinal mushroom Cordyceps taii in mouse models. BMC Complement. Altern. Med. 2015, 15, 216. [Google Scholar] [CrossRef]
  95. Liu, R.M.; Dai, R.; Luo, Y.; Xiao, J.H. Glucose-lowering and hypolipidemic activities of polysaccharides from Cordyceps taii in streptozotocin-induced diabetic mice. BMC Complement. Altern. Med. 2019, 19, 230. [Google Scholar] [CrossRef]
  96. Liu, H.G.; Li, T.; Zhao, Y.L.; Zhang, J.; Wang, Y.Z. Determination of some metabolites of Cordyceps sobolifera. Afr. J. Microbiol. Res. 2011, 5, 5518–5522. [Google Scholar] [CrossRef]
  97. Yang, S.; Zhang, H. Optimization of the fermentation process of Cordyceps sobolifera Se-CEPS and its anti-tumor activity in vivo. J. Biol. Eng. 2016, 10, 8. [Google Scholar] [CrossRef]
  98. Kim, H.S.; Kim, J.Y.; Ryu, H.S.; Shin, B.R.; Kang, J.S.; Kim, H.M.; Kim, Y.O.; Hong, J.T.; Kim, Y.; Han, S.B. Phenotypic and functional maturation of dendritic cells induced by polysaccharide isolated from Paecilomyces cicadae. J. Med. Food 2011, 14, 847–856. [Google Scholar] [CrossRef]
Figure 1. Schematic diagram of the immune regulation mechanism of Cordyceps polysaccharide.
Figure 1. Schematic diagram of the immune regulation mechanism of Cordyceps polysaccharide.
Molecules 29 05107 g001
Table 1. The pure polysaccharides with immunomodulatory effects extracted from Cordyceps.
Table 1. The pure polysaccharides with immunomodulatory effects extracted from Cordyceps.
SourceNameM.W. (kDa)Monosaccharide CompositionStructural CharacteristicsRef.
Cordyceps sinensisCCP433.788GlcComposed of non-reducing terminal D-glcp, (1→4)-linked D-g glcp, and (1→4,6)-linked D-glcp residues [22]
PHP58.14Man (2.49%), Glc (57.1%), Gal (1.43%), and GalA (0.321%)ND[23]
CM-S134.631Gal, Glc, and Xyl with a molar ratio of 3:2:1Main chain is (1→6)-α-d-gal, which is connected at the C2 site with (1,4→6)-α-d-glc at the C1 site[12]
CP2-S1.328Mainly composed of GlcND[24]
OSP27.972Xyl, Man, Glc, and Gal with a molar ratio of 2.9:6.6:166:2.6ND[25]
Cordysinan22.37Man, Gal, and Glc with a molar ratio of 4.4:3.8:1.0Backbone composed of 1,2-Manp residues[26]
UM01-S422.569Man, Glc, Gal, and GalA with a molar ratio of 9.6:4.0:4.4:1.0Backbone composed of α-(1→2)-Manp and with side chains consisting of β-(1→4)-Glcp, β-(1→2)-Galf, terminal α-GalpA and α-Manp[27]
CP-PS12Man, Rha, Ara, Xyl, Glc, and Gal with a molar ratio of 38.37:2.51:2.21:5.22:27.44:24.25ND[28]
Cs-HK136Glc and GalA with a molar ratio of 8:1Linear backbone of (1→3)-linked α-D-Glcp [29]
EPS104Glc and Gal with a molar ratio of 23:1:2.6ND[30]
EPSNDGlc and Man with a molar ratio of 99:1Linear backbone of (1→3)-β-D-Glcp residues[31]
HSWP-2a870.70Glcα-(1→4)-D-glucan[32]
HS002-II44Man, Rib, Rha, GlcA, GalA, Glc, Gal, Xyl, and Ara with a molar ratio of 6.47:2.27:1.25:0.69:0.42:65.89:16.17:2.13:4.26Long backbone of (1→3)-linked α-d-Ribf units (1→4)-linked α-d-Xylp units and (1→4)-linked β-d-Glcp units[33]
NCSP-50976GlcBackbone of (1→4)-linked-α-D-Glcp with a single α-D-Glcp branch substituted at C-6[34]
PS83Glc, Man, Ara, and Gal with a molar ratio of 8:90:1:1ND[35]
UST 200082Glc, Man, and Gal with a molar ratio of 2.4:2:1ND[36]
AEPS-136GlcLinear backbone of (1→3)-linked α-D-Glcp residues with two branches, α-D-Glcp and α-D-Glcp[29]
Cordyceps militarisCM-S134.631Gal, Glc, and Xyl with a molar ratio of 3:2:1Main chain is (1→6)-α-d-Gal, which is connected at the C2 site with (1,4→6)-α-d-Glc at the C1 site[12]
PLCM36Glca 1,6-branched-Glc[37]
HCMP6180Ara, Gal, Glc, Man, and Xyl, with a molar ratio of 2.00:8.01:72.54:15.98:1.02ND[38]
APS576Gal (58.3%), Ara (27.8%), Xyl (7.5%), and Rha (6.4%)Composed of Araf-(1→, →5)-Araf-(1→, →4)-Galp-(1→ and →4)-GalAp-(1→ residues[39]
CMP15.94Glc, Man, Gal, Xyl, Ara, and GlcA with a molar ratio of 81.25:21.96:13.88:3.92:3.58:1.00ND[40]
CMP-W1366Man, Glc, and Gal with a molar ratio of 2.84:1:1.29Main chain composed of 1→3,1→2,3,1→2,4,1→3,4,1→3,6, or 1→2,3,4 glycosidic bond[41]
CMP-S1460Man, Glc, and Gal with a molar ratio of 2.05:1:1.09Lots of residues are 1→,1→6,1→2,1→2,6,1→4, and 1→4,6 linked[41]
CMP Fr II126Glc, Gal, and Man with a molar ratio of 56.4:26.4:17.2Composed of the (1→4) or (1→2)-linked Glcp or Galp residue with a (1→2) or (1→6)-linked Manp, Glcp, or Galp residue as a side chain[42]
CMPB90-15.8Gal, Glc, and Man with a molar ratio of 3.04:1.00:1.45Backbone of (1→6)-linked α-d-Glcp and (1→3)-linked α-d-Glcp residues[43]
EPS-III1.56Man, Glc, and Gal with a molar ratio of 1.68:1:1.83Backbone of →4)-α-D-Galp-(1→[44]
CMP-III49.76Glc, Man, and Gal with a molar ratio of 8.09:1.00:0.25Main linkage types consist of 1→4)-α-D-Glc, 1→4,6)-α-D-Man, 1→)-α-D-Man and 1 → 2,6)-α-D-Gal [45]
SDQCP-119.3Man, Glc, and Gal with a molar ratio of 13.3:1.0:9.7Backbone composed of (1→2)-α-D-Manp and (1→ 4)-β-D-Glcp residues[46]
AESP-II61.52Man, GlcA, Rha, GalA, Glc, Gal, and Ara with a molar ratio of 1.07:5.38:1:3.14:15:6.09: and 4.04ND[47]
CPS-123Rha, Xyl, Man, Glc, and Gla in with a molar ratio of 1:6.43:25.6:16.0:13.8(1→2) linkage Man, (1→4) linkage Xyl, and (1→2) or (1→3) linkage Rha[48]
CM-jd-CPS2NDMan, Glc, and Gla with a molar ratio of 1.52:8.53:1.00Composed of α-glycosidic linkage[49]
CM-jd(Y)-CPSNDMan, Glc, and Gla with a molar ratio of 3.11:1.00:2.12Composed of β-glycosidic linkage[49]
SD-PK5NDGlcA linear β-(1→3)-D-glucan[50]
Cordyceps cicadaeIPS12400Man, Glc, and Gla with a molar ratio of 1.35:6.93:1.0Backbone of →4)-α-D-Glcp (1→ and →3,4)-α-D-Manp (1 → residues [51]
IPS2679Man, Glc, and Gla with a molar ratio of 2.04:1.0:1.87Consists of →4)-α-D-Glcp-(1→, →3,4)-α-D-Manp-(1→ and →2,6)-α-D-Manp-(1→ residues[51]
JCH-130.9Man, Glc, and Gla with a molar ratio of 1.70:1.37:1.00Composed of α-type glycosidic linkage[52]
JCH-2555.3Man, Glc, and Gla with a molar ratio of 5.41:1.04:1.00ND[52]
CP80-125.461Glc, Xyl, and Rha with a molar ratio of 19.04:8.73:1.00Composed of α- and β-glycosidic linkages[53]
Cordyceps kyushuensisCKPS-17153Fuc, Man, Glc, and Gal with a molar ratio of 1:0.92:1.09:0.72Composed of α- and β-glycosidic linkages[54]
CKPS-25945Fuc, Man, and Gal with a molar ratio of 1:0.63:0.61Composed of α- and β-glycosidic linkages[54]
CKPS-35643Fuc, Man, and Gal with a molar ratio of 1:1.65:1.4Composed of α- and β-glycosidic linkages[54]
CKPS-45642Fuc, Man, and Gal with a molar ratio of 1:2.06:1.97Composed of α- and β-glycosidic linkages[54]
Cordyceps taiiPCT-1NDGlc, Man, and Gal with a molar ratio of 5.06:4.21:1.00Composed of α- and β-glycosidic linkages [55]
PCTNDGlc, Gal, and Man with a molar ratio of 1.14:1.00:1.66Composed of series α-(1, 4) glucosidic bond[56]
Abbreviations: Ara, arabinose; Fuc, fucose; GluA, glucuronic acid; Xyl, xylose; Man, mannose; Glc, glucose; Gal, galactose; Rha, rhamnose; GalA, galacturonic acid; GlcA, glucuronic acid. ND, not detected.
Table 2. The pharmacological effect of Cordyceps polysaccharides.
Table 2. The pharmacological effect of Cordyceps polysaccharides.
Species NamePolysaccharide Name/FractionDetails of Pharmacological ActivityCell Line/ModelDosageRef.
Cordyceps sinensisFractionActivates NF-κB pathway; induces M1 phenotype; and upregulates TNF-α, IL-12, and iNOS expression while downregulating IL-10Ana-1 cells25–100 μg/mL[58]
FractionActivates NF-κB pathway and stimulates the release of NO and cytokines IL-1α, IL-1β, IL-10, and TNF-αRAW264.7 cells30–300 μg/mL[59,60]
FractionEnhances macrophage activity, induces differentiation into dendritic cells, and promotes their maturation RAW 264.7 cells0.1–15 μg/mL[61]
FractionPromotes proliferation and enhances the expression of CD4 and CD8 Simulated microgravity-induced murine splenic lymphocytes25–50 μg/mL[63]
FractionIncreases histone H3 acetylation, induces Foxp3 expression in regulatory T cells, and decreases IL-17 and IL-21 expression Colons of mice induced with cyclophosphamide200 mg/kg[65]
FractionRegulates the polarization of Th1/Th2 cells and increases IL-2, IL-12 p40, IFN-γ, TNF-α, IL-4, IL-10, GATA-3, and secretory IgA levelsCyclophosphamide-induced mice25–100 mg/kg[66]
FractionStimulates IL-12, IFN-γ, IL-4, IL-13, IL-6, IL-17, IL-10, TGF-β3, TNF-α, IL-2, IL-21, T-bet, GATA-3, RORγt, and Foxp3 productionCyclophosphamide-induced mice25–100 mg/kg[67]
FractionEnhances lymphocyte proliferation and macrophage phagocytosis activity, reduces IL-4 and IL-17 expression, and increases IL-5 expressionMice exposed to 60Co50–200 mg/kg[28]
FractionAccelerates the recovery of white blood cells, increases the organ index of the thymus and spleen X-ray irradiation-injured mice100–400 mg/kg[69]
FractionElevates thymus index, spleen index, and the number of CD4+ and CD8+ T lymphocytes and macrophages H22 tumor-bearing mice100–400 mg/kg[22]
PSEnhances the serum levels of IgG, IgG1, and IgG2b OVA-immunized mice100–400 μg/mouse[35]
AEPS-1Induces the production of TNF-α, IL-6, and IL-1βRAW264.7 cells25–250 μg/mL[29]
OSP Activates MAPK and PI3K/Akt pathways and induces the production of TNF-α, IL-6, and IL-1βRAW264.7 cells6.25–50 μg/mL[25]
HS002-II Activates NF-κB pathways and induces the production of NO, TNF-α, IL-6, and IL-1βRAW264.7 cells0.2785–4.4 μM[33]
EPSIncreases IL-12, TNF-α, and iNOS expression and upregulates capacity for antigen uptake and activation of T lymphocyte proliferation Mouse dendritic cells25–100 μg/mL[72,73]
EPSIncreases thymus and spleen indices and stimulates the release of TNF-α and INF-γ Cyclophosphamide-induced mice20 mg/kg[31]
UST 2000Activates ERK signaling pathway and promotes proliferation and IL-2, IL-6, and IL-8 secretion Human T lymphocytes6.25–100 μg/mL[36]
PHPReduces the number of Th17 cells and increases the number of Treg cellsDextran sulfate sodium-induced mice400 mg/kg[23]
NCSP-50Induces proliferation and augment the production of NO, IL-1β and TNF-αRAW 264.7 cells25–200 μg/mL[34]
NCSP-50Increases the number of CD4+ T cells; modulates TLR expression; and increases IL-17, IL-21, and TGF-β3 levelsCyclophosphamide-induced mice25–100 mg/kg[68]
CCPActivates TLR4/MyD88/p38 pathway and induces NO, IL-6, and TNF-α productionRAW 264.7 cells1–400 μg/mL[62]
HSWP-2aActivates p38, JNK, and NF-κB pathways and augments phagocytic activity and the production of NO, IL-1β, IL-6, and TNF-αRAW264.7 cells25–200 μg/mL[32]
UM01-S4Activates MAPK and NF-κB pathways; boosts proliferation and phagocytic activity; and stimulates NO, IL-1β, IL-6, IL-12, and TNF-α expressionRAW 264.7 cells0.1–3 μg/mL[27]
CordysinanInduces the release of IL-1β, IL-6, IL-10, TNF-α, MCP-1, MIP-1α, IP-10, and KC RAW 264.7 cells10–100 μg/mL[26]
Cordyceps militarisCP2-SStimulates NO production, phagocytosis, respiratory burst activity, and the secretion of IL-1β and IL-2 RAW264.7 cells50–500 μg/mL[24]
FractionPromotes proliferation and enhances the expression of IL-1β, TNF-α, IFN-γ, and IL-6 THP-1 and EL-4 T cells induced by aflatoxin50−250 µg/mL[78]
FractionIncreases spleen and thymus indices and spleen lymphocyte activity and macrophage function Cyclophosphamide-induced mice17.5–70 mg/kg[82]
FractionStimulates lymphocyte proliferation, boosts serum antibody titers, and elevates serum IFN-γ and IL-4 levelsChickens vaccinated with the Newcastle disease vaccine2–8 mg/mL[83]
FractionSuppresses the secretion of eotaxin, IL-4, IL-5, IL-13, IFN-γ, and IgE Ovalbumin-induced asthma mice 25–100 mg/kg[40,85]
Fraction Stimulates proliferation and enhances NO productionRAW264.7 cells12.5–100 μg/mL[88]
FractionActivates MAPK and NF-κB signaling and increases the production of NO, IL-1β, TNF-α, and IL-6 Mouse primary macrophages10–100 μg/mL[89]
FractionIncreases MHC-I, MHC-II, CD80, and CD86 expression and induces allogeneic T-cell activation Mouse dendritic cells10–100 mg/mL[98]
Polysaccharide-rich extractBoosts splenic lymphocyte activity; strengthens macrophage function; and induces IL-2, IL-4, and IFN-γ expressionCyclophosphamide-induced mice50–200 mg/kg[80,81]
Selenium-rich proteoglycan extractIncreases lymphocyte transformation rate, enhances macrophage clearance, and elevates spleen coefficient Ascites tumor-bearing mice100–200 mg/kg[85]
CMP-Fr-IIIncreases NO, TNF-α, and IL-1β expressionRAW264.7 cells1000 µg/mL[42]
CMP-IIIActivates MAPK and NF-κB pathways and induces NO, TNF-α, and IL-6 productionRAW264.7 cells50–500 μg/mL[45]
SDQCP-1Induces M1 polarization and stimulates NO, TNF-α, IL-6, and IL-10 releaseRAW264.7 cells50−250 µg/mL[46]
SD-PK5Stimulates IL-1β, TNF-α, and COX-2 expressionTHP-1 cells10−250 µg/mL[50]
APSPromotes differentiation into macrophages and increases phagocytic activity and TNF-α, IL12 p40, IL-8, TLR-2, and TLR-4 expressionTHP-1 cells1–100 μg/mL[79]
APSElevates TNF-α and IFN-γ expression and diminishes virus titers in bronchoalveolar lavage fluid and lungs Mice infected with influenza A virus2–8 mg/ml[39]
CMPB90-1Stimulates proliferation and enhances the secretion of IL-2 Mouse spleen lymphocytes250–500 μg/mL[43]
CMPB90-1Shifts tumor-promoting M2 phenotype macrophages to a tumor-killing M1 phenotypeLewis lung carcinoma tumor-bearing mice50–200 mg/kg[51]
PLCMActivates MAPK and NF-κB pathways; enhances phagocytic activity; and increases NO, IL-6, and TNF-α expressionRAW264.7 cells10–200 μg/mL[37]
EPS-IIISafeguards the immune organs of from damage induced by high glucose, leading to an enhancement in spleen index Streptozotocin-induced diabetic mice225 mg/kg[44]
AESP-IIEnhances T and B cell proliferation and raises IL-2, IL-4, IFN-γ, IgG, IgM, and IgA levelsCyclophosphamide-induced mice25–100 mg/kg[47]
JCH-1 and JCH-2Elevate phagocytosis and induce NO, IL-6, TNF-α, and IL-1β expression RAW264.7 cells5–25 μg/mL[52]
IPS1 and IPS2Elevate phagocytosis and induce NO, IL-6, TNF-α, and IL-1β expressionRAW264.7 cells50–400 μg/mL[51]
CP80-1Elevates phagocytosis and induces NO, IL-6, TNF-α, and IL-1β expressionRAW264.7 cells25–100 μg/mL[53]
Cordyceps gunniiFractionElevates the spleen and thymus index, boosts natural killer cell toxicity and lymphocyte proliferation activity, and expedites the recovery of peripheral blood cellsCyclophosphamide-induced mice125–500 mg/kg[92]
FractionElevates thymus and spleen indices, enhances macrophage phagocytosis capacity, and stimulates splenocyte proliferationH22 tumor-bearing mice50–200 mg/kg[93]
Cordyceps taiiPCT-1Enhances proliferation and increases IgG expression Mouse T and B lymphocytes100–400 mg/kg[55]
CTPIncreases thymus index Streptozotocin-induced diabetic rats400 mg/kg[95]
Cordyceps soboliferaFraction Enhances immune organ index, increases IL-2 and TNF-α levels, and elevates ratio of CD8+/CD4+ T cells Colon cancer tumor-bearing mice50–200 mg/kg[97]
Cordyceps kyushuensisCKPS-1, CKPS-2, CKPS-3, and CKPS-4Induce proliferation, enhance phagocytic capacity, and elevate the levels of IL-2 and TNF-α in serumMouse splenocytes and peritoneal macrophages62.5–500 μg/mL[54]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chen, L.; Liu, X.; Zheng, K.; Wang, Y.; Li, M.; Zhang, Y.; Cui, Y.; Deng, S.; Liu, S.; Zhang, G.; et al. Cordyceps Polysaccharides: A Review of Their Immunomodulatory Effects. Molecules 2024, 29, 5107. https://doi.org/10.3390/molecules29215107

AMA Style

Chen L, Liu X, Zheng K, Wang Y, Li M, Zhang Y, Cui Y, Deng S, Liu S, Zhang G, et al. Cordyceps Polysaccharides: A Review of Their Immunomodulatory Effects. Molecules. 2024; 29(21):5107. https://doi.org/10.3390/molecules29215107

Chicago/Turabian Style

Chen, Liping, Xiao Liu, Kaiyue Zheng, Yang Wang, Minglong Li, Yuyu Zhang, Yuan Cui, Sichun Deng, Shiqi Liu, Gaoju Zhang, and et al. 2024. "Cordyceps Polysaccharides: A Review of Their Immunomodulatory Effects" Molecules 29, no. 21: 5107. https://doi.org/10.3390/molecules29215107

APA Style

Chen, L., Liu, X., Zheng, K., Wang, Y., Li, M., Zhang, Y., Cui, Y., Deng, S., Liu, S., Zhang, G., Li, L., & He, Y. (2024). Cordyceps Polysaccharides: A Review of Their Immunomodulatory Effects. Molecules, 29(21), 5107. https://doi.org/10.3390/molecules29215107

Article Metrics

Back to TopTop